Skip to main content
FBLG
NASDAQ Life Sciences

FibroBiologics Doses First Patients in Phase 1/2 Trial for Diabetic Foot Ulcers

Tom Rudovsky · Reported by Reuters
More coverage: Biotech Stocks · Healthcare
Sentiment info
Positive
Importance info
7
Price
$1.08
Mkt Cap
$5.469M
52W Low
$0.952
52W High
$19.8
52W Position info
13% above low
Off High info
95% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

FBLG is trading near its 52-week low of $0.952 (13% above the low) on light trading volume (0.2× avg).

Summary

FibroBiologics has dosed the first patients in its Phase 1/2 clinical trial for Cywc628, a treatment for diabetic foot ulcers. This marks a positive step in the company's pipeline development, providing a much-needed R&D update amidst its severe financial distress. The company recently issued a going concern warning and is actively diluting shareholders through ATM offerings to fund operations.

At the time of this announcement, FBLG was trading at $1.08 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $5.5M. The 52-week trading range was $0.95 to $19.80. This news item was assessed with positive market sentiment and an importance score of 7 out of 10. Source: Reuters.


Price Chart

Share this article

Copied!

FBLG - Latest Insights

FBLG
Oct 08, 2026, 5:15 PM EDT
Filing Type: 8-K
Importance Score:
8
Price at Filing: $1.13
Real-time Price: $0.840 info
Change: -$0.290 (-26%) info
Market Cap: $7.551M info
FBLG
Sep 18, 2026, 4:05 PM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.43
Real-time Price: $0.840 info
Change: -$0.590 (-41%) info
Market Cap: $7.551M info
FBLG
Sep 17, 2026, 4:01 PM EDT
Filing Type: SCHEDULE 13D
Importance Score:
7
Price at Filing: $1.49
Real-time Price: $0.840 info
Change: -$0.645 (-43%) info
Market Cap: $7.551M info
FBLG
Sep 15, 2026, 7:15 AM EDT
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.55
Real-time Price: $0.840 info
Change: -$0.7079 (-46%) info
Market Cap: $7.551M info
FBLG
Aug 11, 2026, 8:30 AM EDT
Source: PR Newswire
Importance Score:
7
Price at Filing: $0.950
Real-time Price: $0.840 info
Change: -$0.110 (-12%) info
Market Cap: $7.551M info